Press Releases and Events
PRESS RELEASES
Press Release | November 10, 2016
Press Release | June 6, 2016
Crinetics Pharmaceuticals Appoints Ajay Madan as Vice President, Development
READ MORE
Press Release | November 2, 2015
The San Diego Union-Tribune: Crinetics raises $40 Million
READ MORE
Press Release | November 2, 2015
Crinetics Pharmaceuticals Completes $40 Million Series A Financing
READ MORE
Press Release | April 27, 2015
Crinetics Pharmaceuticals Appoints Matt Fust, M.B.A., David Clemons, M.D., and John Wallen, Ph.D., J.D. as Corporate, Clinical, and Legal Advisers
READ MORE
Press Release | April 27, 2015
Crinetics Pharmaceuticals Awarded NIH Fast-Track Grant to Develop Somatostatin Receptor Agonist Drugs for Chronic Pain
READ MORE
Press Release | January 28, 2015
Crinetics Pharmaceuticals Awarded $1.5MM NIH Phase-II SBIR Grant to Develop Kisspeptin Receptor Antagonists for PCOS and Other Women’s Health Diseases
READ MORE
Press Release | April 28, 2014
Crinetics Pharmaceuticals Awarded NIH Phase-I SBIR Grant to Develop Somatostatin Receptor Agonist Drugs for Ophthalmic Diseases
READ MORE
Press Release | September 13, 2013
Crinetics Pharmaceuticals Awarded NIH Phase-II SBIR Grant to Develop Drugs for Pituitary Tumors
READ MORE
Press Release | February 7, 2009
Crinetics Pharmaceuticals Awarded National Institutes of Health Small Business Innovative Research Grant to Develop GPCR Biosensors for Drug Discovery
READ MORE
WEBCAST
PRESS RELEASETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
You are now leaving Crinetics.com
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
